3.Nick Lynch- Pistoia Alliance
-
Upload
eagle-genomics-ltd -
Category
Documents
-
view
760 -
download
1
Transcript of 3.Nick Lynch- Pistoia Alliance
![Page 1: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/1.jpg)
• http://pistoiaalliance.org
Pistoia Alliance
April 2011
Eagle Genomics SymposiumNick Lynch
![Page 2: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/2.jpg)
![Page 3: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/3.jpg)
3
NATURE Reviews | Drug Discovery Volume 9 | March 2010
![Page 4: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/4.jpg)
4
![Page 5: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/5.jpg)
![Page 6: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/6.jpg)
NOW
![Page 7: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/7.jpg)
Background—How it all started
In Pistoia, Italy
Meeting of GSK, AZ, Pfizer and Novartis—identified similar challenges and frustrations in discovery informatics
7
![Page 8: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/8.jpg)
Learn from Other Industries
Transportation
Geospatial
Automotive
ClinicalRetail
Banking
Healthcare
![Page 9: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/9.jpg)
Lowering the barriers to innovation by improving inter-operability of R&D business processes through pre competitive collaboration
![Page 10: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/10.jpg)
Pistoia MembershipMarch 2011
![Page 11: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/11.jpg)
Energy
Influence
Delivery
Trust
![Page 12: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/12.jpg)
Networked and Externalised Life Science Research
![Page 13: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/13.jpg)
Chemistry Externalization Processes
![Page 14: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/14.jpg)
Image/quote from Abdul-Malik Shakir
Greater Challenge: Unknown Semantic Collisions
Revealing assumptions is an essential component of effective communication.
![Page 15: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/15.jpg)
Crossing the Chasm
Pistoia is the BRIDGE to cross the chasm to a more agile pre-competitive environment
STANDARDIZE SIMPLIFY CENTRALIZEPISTOIA MEMBERS SUPPLIERS
![Page 16: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/16.jpg)
Our Projects….
Sequence ServicesVocabulary StandardsSESLELN Query
![Page 17: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/17.jpg)
SEQUENCE SERVICESWORKING GROUP
Slide 19
![Page 18: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/18.jpg)
Project Rationale - Sequence ServicesProblem / Opportunity Statement
There is no competitive advantage for each bioscience company to maintain the latest version of the many informatics databases and software tools within their company firewall.
To maintain even a core set of sequence databases, as the Red Queen told Alice: “it takes all the running you can do, to keep in the same place”!
![Page 19: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/19.jpg)
Slide 21
Define standards for the provision of secure access to pre-competitive databases and software tools.
Invite external suppliers to provide those services to multiple consumers who would effectively share the cost of the maintenance.
Proposed Solution
![Page 20: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/20.jpg)
Documentation / Deliverables UpdateSequence Services – Phase 1
• Heavy focus on non-functional requirements in Phase 1 (security, performance, scalability, availability, maintenance, and on-going business model)
• 4 Vendor proof of concept projects currently being evaluated. Slide 22
Ethical hack
![Page 21: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/21.jpg)
Example ScreenShot
Slide 23
![Page 23: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/23.jpg)
Why a Vocabulary Standards Initiative (VSI)?
• A key aspect of our work is naming and identifying:– Genes, Sequences, Diseases, Tissues, Anatomy, Cell Lines, Bioprocesses, Species, Phenotypes,
Compounds, Drugs, Mode of Action, People, Places, Adverse Events, Targets, Reagents, etc, etc...– Many other Pistoia initiatives require support in this area
• There are many gaps, organisations, vocabularies and standards (Semantic & Syntatic)– Syntax: OBO, RDF/OWL, ANSI; Content: GO, FMA, SNOMED SO, OBI, NCI Taxonomy, SAO, CL, ChEBI,
PRO, BioLexicon, ICD-10, NCBI Species, HDO, IDO, MedDRA; Organisations: NCBO, OBO, W3C ..etc– Science is continually evolving, and so are vocabularies - constant flux.
• Connecting data across content providers, academic & internal systems often difficult– Significant branching / ab initio vocabulary development within each organization – No common language
• Leaving this to the external environment to fix is not an option (current position), industry needs to be much more proactive
• While we can create ontologies internally, or in public collaboration, what is lacking is central governance, and a service infrastructure
– Manage vocabulary interfaces– Manage change processes– Promote standards – Promote use– Respond to feedback
• Thus VSI...• This is a BIG challenge, and will not be easy to solve
![Page 24: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/24.jpg)
Power Grid 2010
Power Grid 1940
Power Grid 1900 Local/internal power suppliersNo standards (v, amps, sockets)No national gridLittle innovation in electric apps
Central power suppliersStandard accessNational grid – utility powerLots of innovation in electric apps
1000s of power suppliersStandard supply & accessNational gridMass use of electric applications
The Electric Power Grid Analogy (beyond utility computing...)
c.f. “ The Big Switch” Nicholas Carr 2008
![Page 25: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/25.jpg)
Small number of suppliersFew standards (delivery)No information gridLittle innovation in information useSupplier specific interfaces
1000s of suppliersStandards (content)‘Information & model grid’ – semantic webInnovation in information useUser specific interfaces
Info & Model Grid 2015?
Consumers can combine info from any supplier and tailor to need.
Consumers have stand-alone information from few suppliers.
Info & ModelGrid 2011?
c.f. “ The Big Switch” Nicholas Carr 2008
The Electric Power Grid Analogy (beyond utility computing...)
![Page 26: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/26.jpg)
Standardising Drug Target Types
A Pistoia Vocabulary Standard InitiativeLee Harland, Christopher Larminie
With input from the Pistoia VSI group
PUBLIC DOCUMENT
Pistoia Working Group: VSI
29
![Page 27: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/27.jpg)
High Level Summary
• Representation of a molecular drug target in structured databases is ad-hoc– Single protein-targets are “OK” (being linked via Entrez gene, but this is not an agreed standard)– Multi-protein targets, complexes, biologicals and many more are poorly described, often simply raw text
• This project will focus on industry & suppliers to describe a specification for reporting drug targets within structured content
– Minimal cost, just FTE time required– This could feed into the IMI Open Pharmacology (OPS) call as an industry-publisher requirement– Output would be a specific set of “rules” regarding the representation of complex molecular targets– Aim would not be to define a list of all known targets, this would be out of scope. As will any text-mining
efforts.– Recommendation to suppliers and industry to adopt specification along with industry-generated mappings
for pre-existing targets– Deliverable – specification & publication
• Could be a start to a future, wider phamacological data standard project – All databases providing pharmacological activity content delivered in a standard way– Could gain a quick-start building on MIABE standard
30
![Page 28: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/28.jpg)
Drug Targets
• A ‘simple’ monomer? – HTR1B(or 5ht-1b, 5ht1b, htr1b…etc)
• A ‘stable’ (core) complex – 2(NR1:NR2A)
• A ‘dynamic’ complex – NMDA-MASC
From: A. J. Pocklington, J. D. Armstrong and S. G. N. Grant (2006): Organization of brain complexity — synapse proteome form and function. Briefings in Functional Genomics and Prot 5(1), pp66-73
New Arrivals:
siRNA,
vaccines,
aptamers….
What is the “target” of
insulin?
32
![Page 29: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/29.jpg)
Signpost clearly
![Page 30: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/30.jpg)
What can we do? – Call to Arms
Signpost what we already have
Show the value to Life Science workflows
Vocabulary Standards are critical
Pistoia Alliance can foster this new approach
![Page 31: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/31.jpg)
Acknowledgements
Pistoia Working Group Leads and their groupsSimon Thornber, Richard Bolton, Lee Harland, Ian Dix, Wendy Filsell, Ian Harrow & many others
Our Working Group partners
![Page 32: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/32.jpg)
If you want to go fast, go alone. If you want to go far, go together.
www.pistoiaalliance.org
![Page 33: 3.Nick Lynch- Pistoia Alliance](https://reader036.fdocuments.net/reader036/viewer/2022062418/55501329b4c905af648b4a0f/html5/thumbnails/33.jpg)
Discussion Questions
• What are the barriers to precompetitive collaborations in research, development, commercial, medical, etc. arenas?
• What are the factors that are stimulating precompetitive collaborations?
• What is the “tipping point” and how far away is it?
• More…